Business Wire India
PerkinElmer, Inc. Announced today that its PerkinElmer® SARS-CoV-2 real-time RT-PCR assay CE-IVD marking for use of saliva as a sample type and the option to pool up to five samples collected from individuals suspected of COVID-19 or asymptomatic individuals.
SARS-CoV-2 test using saliva , Is less invasive, reducing the risk of exposure to health workers involved in sample collection and the need for frequent replacement of personal protective equipment.
Labs in countries accepting the CE mark now have the option to accept saliva samples and implement sample pooling using the PerkinElmer SARS-cov-2 real-time RT-PCR assay. Sample pooling using saliva samples is an important advancement made possible by PerkinElmer’s chemistry and rigorous manufacturing systems. The PerkinElmer SARS-CoV-2 real-time RT-PCR assay is designed with the lowest detection limit on the most sensitive SARS-CoV-2 test in the market, accordingly. FDA Reference Panel Comparative data.
Parakh originally received its CE mark in the spring of 2020.
Masood Tolou, PhD Vice President, Masood Tolay, said, “Governments and private organizations are working tirelessly to create the right balance between maintaining the world’s economy, while ensuring safe practices.” And General Manager, Diagnostics, PerkinElmer. “We hope that our newly released saliva-based collection and asymptomatic testing solutions will play a larger role in this effort.”
PerkinElmer continues to work to the extent of improving COVID-19 testing. Company-wide SARS-CoV-2 offerings period High Throughput RNA Extraction, RT-PCR, Automation, Elisa, chemiluminescence, Time resolved fluorescence And Lateral flow based serology test.
PerkinElmer enables scientists, researchers and practitioners to solve their most important challenges in science and healthcare. With a mission focused on innovation for a healthier world, we provide unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically enable customers to have earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of approximately 13,000 employees worldwide is passionate about helping customers build healthy families, improve quality of life, and maintain people’s wellbeing and longevity globally. The company reported revenue of approximately $ 2.9 billion in 2019, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available at 1-877-PKI-NYSE or via www.perkinelmer.com
The content is by Business Wire India. Tech Media is not responsible for the content provided or any link related to this content. Tech Media is not responsible for the accuracy, timeliness or quality of content.